NCT02111317View on ClinicalTrials.gov

A Study to Evaluate the Effect of Verapamil on the Pharmacokinetics of ASP015K in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions

Healthy SubjectsPharmacokinetics of ASP015K

Interventions

DRUG

ASP015K

oral

DRUG

verapamil

oral

Trial Locations (1)

91206

PAREXEL, Glendale

Sponsors

Collaborators (1)

Janssen Biotech, Inc.

All Listed Sponsors

collaborator

Janssen Biotech, Inc.

INDUSTRY

lead

Astellas Pharma Global Development, Inc.

INDUSTRY

NCT02111317 - A Study to Evaluate the Effect of Verapamil on the Pharmacokinetics of ASP015K in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter